Effects of phosphoinositide 3-kinase on protease-induced acute and chronic lung inflammation, remodeling, and emphysema in rats

Chest

Volumn 143, Issue 4, 2013, Pages 1025-1035

  Fang, Xiaocong ^a   Li, Ka ^a   Tao, Xuefei ^a   Chen, Chengshui ^b   Wang, Xiaoying ^a   Wang, Lingyan ^a   Wang, Diane C ^a   Zhang, Yong ^a   Bai, Chunxue ^a   Wang, Xiangdong ^a  

^a FUDAN UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; BUDESONIDE; FIBULIN 5; MESSENGER RNA; PANCREATIC ELASTASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEINASE; SHBM 1009; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CHRONIC DISEASE; EMPHYSEMA; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG EDEMA; MALE; MYOFIBROBLAST; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM;

EID: 84875975846     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1040     Document Type: Article

References (53)

1. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001; 164 (10 pt 2): S28-S38.
2. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004; 1 (3): 176-183.
3. Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR. Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med. 2011; 37 (9): 1421-1431.
4. Locke NR, Royce SG, Wainewright JS, Samuel CS, Tang ML. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am J Respir Cell Mol Biol. 2007; 36 (5): 625-632.
5. Calverley PM, Anderson JA, Celli B, et al; TORCH investigators . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356 (8): 775 - 789.
6. Pauwels RA, Löfdahl CG, Laitinen LA, et al European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med. 1999; 340 (25): 1948-1953.
7. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003; 22 (4): 672-688.
8. Dubaybo BA, Crowell LA, Thet LA. Changes in tissue fibronectin in elastase induced lung injury. Cell Biol Int Rep. 1991; 15 (8): 675-686.
9. Lucey EC, Keane J, Kuang PP, Snider GL, Goldstein RH. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-alpha and interleukin-1β receptordefi cient mice. Lab Invest. 2002; 82 (1): 79-85.
10. Hayes JA, Korthy A, Snider GL. The pathology of elastaseinduced panacinar emphysema in hamsters. J Pathol. 1975; 117 (1): 1-14.
11. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002; 296 (5573): 1655-1657.
12. Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004; 9 (6): 667-676.
13. Hirsch E, Katanaev VL, Garlanda C, et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation . Science. 2000; 287 (5455): 1049-1053.
14. Yum HK, Arcaroli J, Kupfner J, et al. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol. 2001; 167 (11): 6601-6608.
15. Hannigan M, Zhan L, Li Z, Ai Y, Wu D, Huang CK. Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc Natl Acad Sci U S A. 2002; 99(6): 3603- 3608.
16. Laffargue M, Calvez R, Finan P, et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function . Immunity. 2002; 16 (3): 441-451.
17. Ali K, Bilancio A, Thomas M, et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature. 2004; 431 (7011): 1007-1011.
18. Chen C, Fang X, Wang Y, et al. Preventive and therapeutic effects of phosphoinositide 3-kinase inhibitors on acute lung injury. Chest. 2011; 140 (2): 391-400.
19. Conte E, Fruciano M, Fagone E, et al. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms . PLoS ONE. 2011; 6 (10): e24663.
20. Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med. 2009; 179 (10): 894-902.
21. Lim DH, Cho JY, Song DJ, Lee SY, Miller M, Broide DH. PI3K gamma-deficient mice have reduced levels of allergeninduced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol. 2009; 296 (2): L210-219.
22. Alleva E, Santucci D. Guide for the care and use of laboratory animals. Ethology. 1997; 103 (12): 1072-1073.
23. Jansson AH, Smailagic A, Andersson AM, et al. Evaluation of excised lung gas volume measurements in animals with genetic or induced emphysema. Respir Physiol Neurobiol. 2006; 150 (2-3): 240-250.
24. Shaker A, Swietlicki EA, Wang L, et al. Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion. J Clin Invest. 2010; 120 (6): 2081-2093.
25. Russo RC, Guabiraba R, Garcia CC, et al. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol. 2009; 40 (4): 410-421.
26. Kuang PP, Joyce-Brady M, Zhang XH, Jean JC, Goldstein RH. Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-βand phosphatidylinositol 3-kinase activity. Am J Physiol Cell Physiol. 2006; 291 (6): C1412-C1421.
27. Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 2008; 29 (12): 2243-2251.
28. Toimela T, Tähti H, Ylikomi T. Comparison of an automated pattern analysis machine vision time-lapse system with traditional endpoint measurements in the analysis of cell growth and cytotoxicity. Altern Lab Anim. 2008; 36 (3): 313-325.
29. Chen Y, Chang L, Li W, et al. Thioredoxin protects fetal type II epithelial cells from hyperoxia-induced injury. Pediatr Pulmonol. 2010; 45 (12): 1192-1200.
30. Yang SJ, Chen HM, Hsieh CH, et al. Akt pathway is required for oestrogen-mediated attenuation of lung injury in a rodent model of cerulein-induced acute pancreatitis. Injury. 2011; 42 (7): 638-642.
31. Lee JP, Li YC, Chen HY, et al. Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils . Acta Pharmacol Sin. 2010; 31 (7): 831-838.
32. Peng XQ, Damarla M, Skirball J, et al. Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung. Acta Pharmacol Sin. 2010; 31 (2): 175-183.
33. Fakhrzadeh L, Laskin JD, Laskin DL. Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-alpha following ozone inhalation. Toxicol Appl Pharmacol. 2008; 227 (3): 380-389.
34. Schäcke H, Döcke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96 (1): 23-43.
35. Jansson AH, Eriksson C, Wang X. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vascul Pharmacol. 2005; 43 (2): 101-111.
36. Inoue K, Yanagisawa R, Koike E, et al. Effects of carbon black nanoparticles on elastase-induced emphysematous lung injury in mice. Basic Clin Pharmacol Toxicol. 2011; 108 (4): 234-240.
37. Boyer L, Plantier L, Dagouassat M, et al. Role of nitric oxide synthases in elastase-induced emphysema. Lab Invest. 2011; 91 (3): 353-362.
38. Kosmider B, Messier EM, Chu HW, Mason RJ. Human alveolar epithelial cell injury induced by cigarette smoke. PLoS ONE. 2011; 6 (12): e26059.
39. McGowan SE, Grossmann RE, Kimani PW, Holmes AJ. Platelet-derived growth factor receptor-alpha-expressing cells localize to the alveolar entry ring and have characteristics of myofibroblasts during pulmonary alveolar septal formation. Anat Rec (Hoboken). 2008; 291 (12): 1649-1661.
40. Kuang PP, Goldstein RH, Liu Y, Rishikof DC, Jean JC, Joyce-Brady M. Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am J Physiol Lung Cell Mol Physiol. 2003; 285 (5): L1147-L1152.
41. Fagone E, Conte E, Gili E, et al. Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Exp Lung Res. 2011; 37 (3): 162-174.
42. Kramer EL, Mushaben EM, Pastura PA, et al. Early growth response-1 suppresses epidermal growth factor receptormediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol. 2009; 41 (4): 415-425.
43. Kramer EL, Hardie WD, Mushaben EM, et al. Rapamycin decreases airway remodeling and hyperreactivity in a transgenic model of noninflammatory lung disease. J Appl Physiol. 2011; 111 (6): 1760-1767.
44. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1βinduces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest. 2001; 107 (12): 1529-1536.
45. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005; 32 (4): 311-318.
46. Kitamura H, Cambier S, Somanath S, et al. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ 8-mediated activation of TGF-β. J Clin Invest. 2011; 121 (7): 2863-2875.
47. Hur GY, Lee SY, Lee SH, et al. Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Exp Mol Med. 2007; 39 (3): 367-375.
48. Wang M, Liu T, Wang D, Zheng Y, Wang X, He J. Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits. J Transl Med. 2011; 9-61.
49. Wang XD, Liotta L. Clinical bioinformatics: a new emerging science. J Clin Bioinforma. 2011; 1 (1): 1.
50. Wang XD. Role of clinical bioinformatics in the development of network-based biomarkers. J Clin Bioinforma. 2011; 1(1): 28.
51. Wu DJ, Rice CM, Wang XD. Cancer bioinformatics: a new approach to systems clinical medicine. BMC Bioinformatics. 2012; 13-71.
52. Fang X, Bai C, Wang XD. Bioinformatics insights into acute lung injury/acute respiratory distress syndrome. Clinical and Translational Medicine. 2012; 1-9.
53. Abraham E, Marincola FM, Chen Z, Wang XD. Clinical and translational medicine: integrative and practical science: an initial editorial for this new journal. Clinical and Translational Medicine. 2012; 1-1.